High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — SAN JUAN, Puerto Rico — Two inhibitors from the same family of immune checkpoints have produced high response rates and evidence of durability in preliminary studies of advanced gynecologic cancers. Patients with platinum resistance…



